Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

FDA Oncologic Drugs Advisory Committee meets for two days in November

Oct. 30, 1998

Successful completion of phase I/II clinical trial of VIMRxyn in brain cancer

Oct. 30, 1998

Camptothecin analogues and prodrugs described in patent literature by SCRAS

Oct. 30, 1998

Vitamin D analogue Ro-25-9716 potentially useful in treating myeloid leukemia

Oct. 30, 1998

Novel class of microtubule-destabilizing agents synthesized and evaluated at Kansas State

Oct. 29, 1998

Difluoronucleoside antineoplastic and antiherpesvirus agents from Lilly

Oct. 29, 1998

Human trials of new liposomal ether lipid approved by FDA

Oct. 28, 1998

Schering-Plough obtains promising results in phase I study of p53 gene therapy for NSCLC

Oct. 28, 1998

Genetronics targets prostate cancer as a new indication for electroporation therapy

Oct. 28, 1998

Clinical, preclinical efficacy of Neovastat featured at recent congress

Oct. 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...